Skin Necrosis and Purpura Fulminans in Children With and Without Thrombophilia—A Tertiary Center's Experience

REFERENCES

• Price VE, Ledingham DL, Krümpel A, Chan AK. Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med. 2011;16:318–322.
   PubMed Web of Science ®Google Scholar
• Chalmers E, Cooper P, Forman K, et al. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child. 2011;96:1066–1071.
   PubMed Web of Science ®Google Scholar
• Rezaie AR. Regulation of the protein C anticoagulant and antiinflammatory pathways. Curr Med Chem. 2010;17:2059–2069.
   PubMed Web of Science ®Google Scholar
• Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet. 1983;2:1165–1168.
   PubMed Web of Science ®Google Scholar
• Millar DS, Johansen B, Berntorp E, et al. Molecular genetic analysis of severe protein C deficiency. Hum Genet. 2000;106:646–653.
   PubMed Web of Science ®Google Scholar
• Goldenberg NA, Manco-Johnson MJ. Protein C deficiency. Haemophilia. 2008;14:1214–1221.
   PubMed Web of Science ®Google Scholar
• Ohga S, Kang D, Kinjo T, et al. Paediatric presentation and outcome of congenital protein C deficiency in Japan. Haemophilia. 2013;19:378–384.
   PubMed Web of Science ®Google Scholar
• Gómez E, Ledford MR, Pegelow CH, Reitsma PH, Bertina RM. Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost. 1994;71:723–726.
   PubMed Web of Science ®Google Scholar
• Van Walderveen MC, Berry LR, Atkinson HM, Chan AK. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va. Thromb Haemost. 2010;103:910–919.
   PubMed Web of Science ®Google Scholar
• Hoshi S, Hijikata M, Togashi Y, et al. Protein C deficiency in a family with thromboembolism and identified gene mutations. Intern Med. 2007;46:997-1003.
   PubMed Web of Science ®Google Scholar
• Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost. 1990;16:299–309.
   PubMed Web of Science ®Google Scholar
• Colman RW, Stewart G, Budzynski A, et al. Thrombosis and hemostasis. Nature. 1979;282:676.
   PubMed Web of Science ®Google Scholar
• Seligsohn U, Lubetsky A. Hereditary thrombophilia. In: Kaushansky K, Beutler E, Seligsohn U, Lichtman MA, Kipps TJ, Prchal JD, eds. Williams Hematology. 8th ed. New York: McGraw Hill Medical; 2008: 2121–2146.
   Google Scholar
• Zimbelman J, Lefkowitz J, Schaeffer C, et al. Unusual complications of warfarin therapy: skin necrosis and priapism. J Pediatr. 2000;137:266–268.
   PubMed Web of Science ®Google Scholar
• Dreyfus M, Masterson M, David M, et al. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost. 1995;21:371–381.
   PubMed Web of Science ®Google Scholar
• Hartman K, Manco-Johnson MJ, Rawlings JS, Bower DJ, Marlar RA. Homozygous protein C deficiency: early treatment with warfarin. Am J Pediatr Hematol Oncol. 1989;11:395–401.
   PubMedGoogle Scholar
• Bernard GR, Vincent JL, Laterre PF, et al.; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Knapp-Clevenger R. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency. J Pediatr Hematol Oncol. 2004;26:25–27.
   PubMed Web of Science ®Google Scholar
• Valdman A, Fischer D, Wong FY, et al. Human protein c concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patient. Crit Care. 2010;14:R156.
   Google Scholar
• Piccini B, Capirchio L, Lenzi L, et al. Continuous subcutaneous infusion of protein C concentrate using an insulin pump in a newborn with congenital protein C deficiency. Blood Coagul Fibrinol. 2014;5:522–526.
   Google Scholar
• de Kort EH, Vrancken SL, van Heijst AF, Binkhorst M, Cuppen MP, Brons PP. Long-term subcutaneous protein C replacement in neonatal severe protein C deficiency. Pediatrics. 2011;127:e1338–1342.
   Google Scholar
• Petäjä J, Fernández JA, Gruber A, Griffin JH. Anticoagulant synergism of heparin and activated protein C in vitro. J Clin Invest. 1997;99:2655–2663.
   PubMed Web of Science ®Google Scholar
• Fluri S, Kaczala GW, Leibundgut K, Alberio L. Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment. Pediatr Emerg Care. 2010;26:932–934.
   PubMed Web of Science ®Google Scholar
• Thomson JJ, Retter A, Hunt BJ. Novel management of post varicella purpura fulminans owing to severe acquired protein S deficiency. Blood Coagul Fibrinol. 2010;21:598–600.
   PubMed Web of Science ®Google Scholar
• Regnault V, Boehlen F, Ozsahin H, et al. Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation. J Thromb Haemost. 2005;3:1243–1249.
   PubMed Web of Science ®Google Scholar
• Hermans C, Eeckhoudt S, Lambert C. Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency. Thromb Haemost. 2012;107:1189–1191.
   PubMed Web of Science ®Google Scholar
• Martinelli I, Bucciarelli P, Artoni A, et al. Anticoagulant treatment with rivaroxaban in severe protein S deficiency. Pediatrics. 2013;132:e1435–e1439.
   PubMed Web of Science ®Google Scholar
• Fareed J, Thethi I, Hoppensteadt D. Old versus new oral anticoagulants: focus on pharmacology. Annu Rev Pharmacol Toxicol. 2012;52:79–99.
   PubMed Web of Science ®Google Scholar
• Bauman ME, Black K, Bauman ML, Kuhle S, Bajzar L, Massicotte MP. Warfarin induced coagulopathy in children: assessment of a conservative approach. Arch Dis Child. 2011;96:164–167.
   PubMed Web of Science ®Google Scholar
• Payne JH. Aspects of anticoagulation in children. Br J Haematol. 2010;150:259–277.
   PubMed Web of Science ®Google Scholar